Hydrocortisone butyrate and Erythema multiforme - a phase IV clinical study of FDA data


Erythema multiforme is found among people who take Hydrocortisone butyrate, especially for people who are male, 20-29 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Hydrocortisone butyrate and have Erythema multiforme. It is created by eHealthMe based on reports of 767 people who have side effects when taking Hydrocortisone butyrate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

767 people reported to have side effects when taking Hydrocortisone butyrate.
Among them, 7 people (0.91%) have Erythema multiforme.

What is Hydrocortisone butyrate?

Hydrocortisone butyrate has active ingredients of hydrocortisone butyrate. eHealthMe is studying from 770 Hydrocortisone butyrate users for its effectiveness, alternative drugs and more.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 2,866 drugs and 2,736 conditions by eHealthMe.

Number of Hydrocortisone butyrate and Erythema multiforme reports submitted per year:

Could Hydrocortisone butyrate cause Erythema multiforme?

Time on Hydrocortisone butyrate when people have Erythema multiforme *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Erythema multiforme when taking Hydrocortisone butyrate *:

  • female: 20 %
  • male: 80 %

Age of people who have Erythema multiforme when taking Hydrocortisone butyrate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 50 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 25 %
  • 60+: 25 %

Common drugs people take besides Hydrocortisone butyrate *:

  1. Lamisil: 3 people, 42.86%
  2. Prednisolone: 2 people, 28.57%
  3. Polaramine: 2 people, 28.57%
  4. Paracetamol: 2 people, 28.57%
  5. Hydroxyzine: 2 people, 28.57%
  6. Diprosone: 2 people, 28.57%
  7. Chloramphenicol: 2 people, 28.57%
  8. Atarax: 2 people, 28.57%
  9. Amlodipine: 2 people, 28.57%
  10. Zyrtec: 1 person, 14.29%

Common side effects people have besides Erythema multiforme *:

  1. Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 57.14%
  2. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 28.57%
  3. Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 2 people, 28.57%
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 28.57%
  5. Dyshidrotic Eczema (skin condition in which blisters develop on the soles of your feet and/or the palms of hands): 1 person, 14.29%
  6. Hepatic Function Abnormal: 1 person, 14.29%
  7. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 14.29%
  8. Febrile Neutropenia (fever with reduced white blood cells): 1 person, 14.29%
  9. Eosinophilia (eosinophil count in the peripheral blood exceeds): 1 person, 14.29%
  10. Enterococcal Infection: 1 person, 14.29%

Common conditions people have *:

  1. Psoriasis (immune-mediated disease that affects the skin): 1 person, 14.29%
  2. Interstitial Lung Disease: 1 person, 14.29%
  3. B Precursor Type Acute Leukaemia (lymphoid cancer): 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Hydrocortisone butyrate and have Erythema multiforme?

Check whether Erythema multiforme is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Erythema multiforme and when was it recovered:

Expand to all the drugs that have ingredients of hydrocortisone butyrate:

Alternative drugs to, pros and cons of Hydrocortisone butyrate:

Erythema multiforme treatments and more:

COVID vaccines that are related to Erythema multiforme:

Common drugs associated with Erythema multiforme:

All the drugs that are associated with Erythema multiforme:

Common conditions associated with Erythema multiforme:

All the conditions that are associated with Erythema multiforme:

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone butyrate (the active ingredients of Hydrocortisone butyrate) and Hydrocortisone butyrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: